مبيعات تغيير تاريخ
Agios Pharmaceuticals USD 55.38M 10.64M 2026-09
Alnylam Pharmaceuticals USD 1.46B 170M 2026-09
Amgen USD 10.4B 300M 2026-09
Biogen USD 2.8B 60M 2026-09
BioMarin Pharmaceutical USD 1.03B 40M 2026-09
Daiichi Sankyo JPY 592.49B 17.75B 2026-09
Exelixis USD 658.69M 30M 2026-09
Gilead Sciences USD 8.3B 500M 2026-09
Glaxosmithkline GBP 8.89B 1.2B 2026-09
Incyte USD 1.56B 110M 2026-09
MacroGenics USD 32.83M 12.03M 2026-06
Moderna USD 1.31M 98.69M 2026-09
Novartis USD 14.52B 112M 2026-09
Pfizer USD 16.6B 1.57B 2026-09
PTC Therapeutics USD 357.8M 3.2M 2026-09
Puma Biotechnology USD 80.54M 33.46M 2024-09
Regeneron Pharmaceuticals USD 5.12B 830M 2026-09
Roche Holding CHF 30.36B 14.71B 2026-06
Sangamo BioSciences USD 356K 125K 2024-06
Sarepta Therapeutics USD 381.4M 19.9M 2026-09
Takeda JPY 1.19T 32.9B 2026-09
TG Therapeutics USD 259.94M 19.6M 2026-09
Ultragenyx Pharmaceutical USD 173M 41M 2026-09
Vanda Pharmaceuticals USD 198.77M 151.12M 2024-12
Vertex Pharmaceuticals USD 3.44B 110M 2026-09